For AF screening, enrichment strategies using circulating biomolecules associated with AF, stroke, and heart failure (BMP10, NT-proBNP, troponin, angiopoietin-2, fibroblast growth factor-23, and others) may be useful. This evidence concerns the gene FGF23 and atrial fibrillation.